App-Quantinova.ai

Effect of Therapeutic-Dose Heparin on Acute Kidney Injury in Non-Critically Ill Hospitalized Patients With Covid-19 The Activ4a and Attac Randomized Trial

Nathaniel Smilowitz - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

Heparin

GWAS Meta-Analysis in SCAD, a Women Predominant Ischemic Heart Disease, Reveals Common Variants and Genes Related to Artery Integrity and Tissue-Mediated Coagulation

David Adlam - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

TIMP-3 secretion inducer

Geographic Differences Among Patients With Acute Myocardial Infarction in the PARADISE-MI Trial

Jawad H Butt - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Left ventricular dysfunction

N/A

The Location of Combined High-Risk Low Endothelial Shear Stress and High Plaque Structural Stress is Distant From the Minimal Lumen Area in the Majority of Coronary Plaques Responsible for Major Adverse Cardiac Events

Mona Ahmed - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Reduced Apoj-Glyc Serum Levels Identify Patients With Cardiac Ischemic Events Among Those Attending the Emergency Department With Chest Pain

Juan-Carlos C Kaski - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Prognostic Value of a Progressive Decrease in Apoj-Glyc Levels in Patients Attending A&E Departments With Suspected Acute Coronary Syndrome or Angina-Like Pain

Juan-Carlos C Kaski - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Differential Benefit of Non-Invasive Cardiac Stress Testing by HEART Score Risk Stratification

Aniket A Kawatkar - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Clopidogrel Monotherapy Associates With Increased Mortality Compared With Aspirin Independently of Cardiometabolic Risk Factors

Rohin K Reddy - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Clopidogrel bisulfate

Safety, Pharmacokinetics, and Pharmacodynamics of AZD3366 Alone and in Combination With Aspirin and Ticagrelor in Healthy Subjects

Dimitris Kardassis - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Ticagrelor

The Effect of Protease-Activated Receptor-1 Inhibition With Vorapaxar in Post-mi and Nstemi Patients on Selected Biomarkers Reflecting Endothelial Function

Dennis W Nilsen - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Vorapaxar

The Effects of Celecoxib on Endothelial Function in Healthy Volunteers; A Double Blind, Placebo Controlled Randomised Trial

Ricky Vaja - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Celecoxib

Renal Function Underpins Cox-2 Methylarginine Axis in Mouse and Man

Plinio M Ferreira - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Prostaglandin

Using Renal-Specific Cyclo-Oxygenase-2-Deficient Mice to Understand the Pro-Thrombotic Effects of Non-Steroidal Anti-Inflammatory Drugs

Maria Lopes Pires - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Acetylcholine

Non-Invasive Assessment of Systemic Microvascular Function in Patients With Severe Aortic Stenosis Pre- and Post- Transcatheter Aortic Valve Intervention

Jonathan A Mailey - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

CircRNA-miRNA-mRNA Networks Regulate Endothelial Function in Ischemic Heart Disease

Maryam Anwar - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Defective Vascular Smooth Muscle Cell Tafazzin Impairs Mitochondrial Function and Promotes Atherosclerosis

Cindy Dong - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Angiology

Coronary Artery Disease

N/A

Selective Inhibition of Rho Kinase 2 Limits No Re-Flow in Rat Hearts Following Ischemia/Reperfusion

Lucie Pearce - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Angiology

Myocardial infarction

Fasudil

Psat1 Promotes Serine Synthesis Pathway and Cardiac Regeneration After Myocardial Infarction

Ajit Magadum - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Dissection of Cardiomyocyte versus Fibroblast Effects of Interleukin-11 in Heart Failure

Mark Sweeney - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

IL-11

Sodium-Glucose Cotransporter-2 Inhibitors Are Associated With Lower Risks of Hospitalization for Heart Failure and All-Cause Mortality in Patients With Diabetes Mellitus and Cancer

Cho Han Chiang - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Type 2 diabetes mellitus

N/A

Filters

45280 Abstracts